CENTEK(SZ:000931) Sou Hu Cai Jing·2026-02-09 13:15Group 1 - The core point of the article highlights the recent performance of Zhongguancun (000931), which closed at 5.3 yuan on February 9, 2026, with a 1.92% increase and a turnover rate of 2.12% [1] - The stock experienced a net inflow of main funds amounting to 11.89 million yuan, representing 14.15% of the total transaction amount, while retail investors saw a net outflow of 9.45 million yuan, accounting for 11.23% of the total [1] - For the first three quarters of 2025, Zhongguancun reported a main revenue of 1.882 billion yuan, a year-on-year decrease of 2.46%, and a net profit attributable to shareholders of 49.49 million yuan, down 4.14% year-on-year [1] Group 2 - The company’s main business segments include biopharmaceuticals and health products, elderly medical services, commercial concrete, and other businesses [1] - The biopharmaceutical and health products segment involves the research, manufacturing, and sales of various pharmaceutical forms, including chemical drugs, traditional Chinese medicine, and medical devices [1] - The elderly medical services segment encompasses centralized elderly care, home care services, health management, and internet hospital services [1]